ArticleCancer science2017

CS2164, a novel multi-target inhibitor against tumor angiogenesis, mitosis and chronic inflammation with anti-tumor potency.

You Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.